A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time. It is the first to quantify tumor changes in glioblastoma patients receiving MRI-guided radiation therapy.
Tag: ASTRO 2024
Timing matters when adding immunotherapy to chemoradiation for patients with limited-stage small cell lung cancer
People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds.
Additional research highlights from the 2024 ASTRO Annual Meeting
In addition to the studies featured on the press program (details here) for the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting, the following studies were recommended by ASTRO experts and may be of interest to journalists.